Table 1 Characteristic of participants

Age, year

66 (40–92)

66 (40–91)

68 (41–92)

BSA

1.65 (1.32–2.14)

1.70 (1.35–2.14)

1.52 (1.32–1.96)

Smoking, n (%)

161 (39.5%)

157 (60.2%)

4 (2.7%)

Alcohol, n (%)

86 (21.1%)

85 (32.6%)

1 (0.7%)

SBP, mmHg

149.3 ± 24.6

146.2 ± 24.2

154.9 ± 24.5

DBP, mmHg

83.3 ± 13.7

82.9 ± 14.0

83.8 ± 13.2

CAD, n (%)

175 (42.9%)

132 (50.6%)

43 (29.3%)

Hypertension, n (%)

268 (65.7%)

160 (61.3%)

108 (73.5%)

DM, n (%)

97 (23.8%)

55 (21.1%)

42 (28.6%)

Hyperlipidaemia, n (%)

24 (5.9%)

16 (6.1%)

8 (5.4%)

Cerebral infarction, n (%)

183 (44.9%)

107 (41%)

76 (51.7%)

COPD, n (%)

15 (3.7%)

14 (5.4%)

1 (0.7%)

Carotid atherosclerosis, n (%)

251 (61.5%)

164 (62.8%)

87 (59.2%)

Carotid artery stenosis, n (%)

50 (12.3%)

35 (13.4%)

15 (10.2%)

Aortic sclerosis, n (%)

146 (35.8%)

101 (38.7%)

45 (30.6%)

CIMT, mm

1.50 (0.5–6.7)

1.70 (0.6–6.7)

1.30 (0.5–5.0)

Triglyceride, mmol/L

1.47 (0.35–8.87)

1.35 (0.43–8.87)

1.6 (0.35–8.51)

TC, mmol/L

4.40 (0.52–8.58)

4.25 (0.52–7.95)

4.62 (2.34–8.58)

HDL-C, mmol/L

1.19 (0.54–2.40)

1.15 (0.64–2.32)

1.26 (0.54–2.40)

LDL-C, mmol/L

2.49 (0.87–6.47)

2.41 (0.87–5.81)

2.66 (1.01–6.47)

Lipoprotein (a), mg/L

194 (15–1398)

186 (24–1214)

213 (15–1398)

CRP, mg/L

4.1 (1–189)

4.3 (1–164)

3.4 (1–189)

WBC count

6.6 (3–19.2)

6.63 (3–19.2)

6.4 (3.6–17.3)

Platelet count

207 (68–576)

193 (68–424)

234 (81–576)

RBC

4.4 (2.1–15.9)

4.5 (2.1–15.9)

4.2 (3.07–5.65)

Hemoglobin, g/L

132 (66–188)

138 (66–188)

126 (85–152)

Statin agent, n (%)

103 (25.2%)

67 (25.7%)

36 (24.5%)

Anti-platelets agent, n (%)

222 (54.4%)

150 (57.5%)

72 (49%)

Anti-hypertension agent, n (%)

194 (47.5%)

118 (45.2%)

76 (51.7%)

Hypoglycemic agent, n (%)

56 (13.7%)

29 (11.1%)

27 (18.4%)